Table 5

One year postdischarge outcomes of the study patients

CharacteristicsTotal (n=1640)STEMI/new LBBB (n=421)UA/NSTEMI (n=1219)p Value
Mortality70 (4.3)22 (5.2)48 (3.9)0.267
 Cardiac50 (71.4)19 (86.4)31 (64.6)0.061
 Non-cardiac20 (28.6)3 (13.6)17 (35.4)
Acute coronary syndrome156 (9.5)36 (8.5)120 (9.8)0.427
Congestive heart failure54 (3.3)12 (2.8)42 (3.4)0.551
CABG117 (7.1)38 (9.0)79 (6.5)0.081
PCI161 (9.8)67 (15.9)94 (7.7)<0.0001
Stroke/TIA20 (1.2)5 (1.2)15 (1.2)0.940
Bleeding23 (1.4)6 (1.4)17 (1.4)0.969
 Severe7 (30.4)2 (33.3)5 (29.4) 
 Moderate4 (17.4)1 (16.7)3 (17.6)
 Mild12 (52.2)3 (50.0)9 (52.9)
MACCE*246 (15.0)63 (14.9)183 (15.0)0.996
  • *MACCE including stroke/TIA, acute coronary syndrome and mortality.

  • CABG, coronary artery bypass grafting surgery; LBBB, left bundle branch block; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; TIA, transient ischaemic attack; UA, unstable angina.